Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Cell Therapy
1.2.3 Viral Vectors
1.2.4 Plasmid
1.3 Market by Application
1.3.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular and Gene Therapy CDMO Market Perspective (2018-2033)
2.2 Global Cellular and Gene Therapy CDMO Growth Trends by Region
2.2.1 Cellular and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cellular and Gene Therapy CDMO Historic Market Size by Region (2018-2023)
2.2.3 Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2033)
2.3 Cellular and Gene Therapy CDMO Market Dynamics
2.3.1 Cellular and Gene Therapy CDMO Industry Trends
2.3.2 Cellular and Gene Therapy CDMO Market Drivers
2.3.3 Cellular and Gene Therapy CDMO Market Challenges
2.3.4 Cellular and Gene Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cellular and Gene Therapy CDMO by Players
3.1.1 Global Cellular and Gene Therapy CDMO Revenue by Players (2018-2023)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cellular and Gene Therapy CDMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cellular and Gene Therapy CDMO Market Concentration Ratio
3.4.1 Global Cellular and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular and Gene Therapy CDMO Revenue in 2022
3.5 Global Key Players of Cellular and Gene Therapy CDMO Head office and Area Served
3.6 Global Key Players of Cellular and Gene Therapy CDMO, Product and Application
3.7 Global Key Players of Cellular and Gene Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular and Gene Therapy CDMO Breakdown Data by Type
4.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Type (2018-2023)
4.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033)
5 Cellular and Gene Therapy CDMO Breakdown Data by Application
5.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Application (2018-2023)
5.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cellular and Gene Therapy CDMO Market Size (2018-2033)
6.2 North America Cellular and Gene Therapy CDMO Market Size by Type
6.2.1 North America Cellular and Gene Therapy CDMO Market Size by Type (2018-2023)
6.2.2 North America Cellular and Gene Therapy CDMO Market Size by Type (2024-2033)
6.2.3 North America Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
6.3 North America Cellular and Gene Therapy CDMO Market Size by Application
6.3.1 North America Cellular and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 North America Cellular and Gene Therapy CDMO Market Size by Application (2024-2033)
6.3.3 North America Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
6.4 North America Cellular and Gene Therapy CDMO Market Size by Country
6.4.1 North America Cellular and Gene Therapy CDMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
6.4.3 North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cellular and Gene Therapy CDMO Market Size (2018-2033)
7.2 Europe Cellular and Gene Therapy CDMO Market Size by Type
7.2.1 Europe Cellular and Gene Therapy CDMO Market Size by Type (2018-2023)
7.2.2 Europe Cellular and Gene Therapy CDMO Market Size by Type (2024-2033)
7.2.3 Europe Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Application
7.3.1 Europe Cellular and Gene Therapy CDMO Market Size by Application (2018-2023)
7.3.2 Europe Cellular and Gene Therapy CDMO Market Size by Application (2024-2033)
7.3.3 Europe Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
7.4 Europe Cellular and Gene Therapy CDMO Market Size by Country
7.4.1 Europe Cellular and Gene Therapy CDMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
7.4.3 Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cellular and Gene Therapy CDMO Market Size (2018-2033)
8.2 China Cellular and Gene Therapy CDMO Market Size by Type
8.2.1 China Cellular and Gene Therapy CDMO Market Size by Type (2018-2023)
8.2.2 China Cellular and Gene Therapy CDMO Market Size by Type (2024-2033)
8.2.3 China Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
8.3 China Cellular and Gene Therapy CDMO Market Size by Application
8.3.1 China Cellular and Gene Therapy CDMO Market Size by Application (2018-2023)
8.3.2 China Cellular and Gene Therapy CDMO Market Size by Application (2024-2033)
8.3.3 China Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cellular and Gene Therapy CDMO Market Size (2018-2033)
9.2 Asia Cellular and Gene Therapy CDMO Market Size by Type
9.2.1 Asia Cellular and Gene Therapy CDMO Market Size by Type (2018-2023)
9.2.2 Asia Cellular and Gene Therapy CDMO Market Size by Type (2024-2033)
9.2.3 Asia Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
9.3 Asia Cellular and Gene Therapy CDMO Market Size by Application
9.3.1 Asia Cellular and Gene Therapy CDMO Market Size by Application (2018-2023)
9.3.2 Asia Cellular and Gene Therapy CDMO Market Size by Application (2024-2033)
9.3.3 Asia Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
9.4 Asia Cellular and Gene Therapy CDMO Market Size by Region
9.4.1 Asia Cellular and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cellular and Gene Therapy CDMO Market Size by Region (2018-2023)
9.4.3 Asia Cellular and Gene Therapy CDMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Cellular and Gene Therapy CDMO Introduction
11.1.4 Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.1.5 Catalent Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Cellular and Gene Therapy CDMO Introduction
11.2.4 Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.2.5 Lonza Recent Developments
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Cellular and Gene Therapy CDMO Introduction
11.3.4 Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.3.5 Charles River Recent Developments
11.4 The Discovery Labs
11.4.1 The Discovery Labs Company Details
11.4.2 The Discovery Labs Business Overview
11.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Introduction
11.4.4 The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.4.5 The Discovery Labs Recent Developments
11.5 BIOCENTRIQ
11.5.1 BIOCENTRIQ Company Details
11.5.2 BIOCENTRIQ Business Overview
11.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Introduction
11.5.4 BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.5.5 BIOCENTRIQ Recent Developments
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.7 Exothera
11.7.1 Exothera Company Details
11.7.2 Exothera Business Overview
11.7.3 Exothera Cellular and Gene Therapy CDMO Introduction
11.7.4 Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.7.5 Exothera Recent Developments
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Introduction
11.8.4 WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.8.5 WuXi AppTec Recent Developments
11.9 Pharmaron
11.9.1 Pharmaron Company Details
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Cellular and Gene Therapy CDMO Introduction
11.9.4 Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.9.5 Pharmaron Recent Developments
11.10 OBiO
11.10.1 OBiO Company Details
11.10.2 OBiO Business Overview
11.10.3 OBiO Cellular and Gene Therapy CDMO Introduction
11.10.4 OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.10.5 OBiO Recent Developments
11.11 Cell Therapies
11.11.1 Cell Therapies Company Details
11.11.2 Cell Therapies Business Overview
11.11.3 Cell Therapies Cellular and Gene Therapy CDMO Introduction
11.11.4 Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.11.5 Cell Therapies Recent Developments
11.12 AGC Biologics
11.12.1 AGC Biologics Company Details
11.12.2 AGC Biologics Business Overview
11.12.3 AGC Biologics Cellular and Gene Therapy CDMO Introduction
11.12.4 AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.12.5 AGC Biologics Recent Developments
11.13 Cytiva
11.13.1 Cytiva Company Details
11.13.2 Cytiva Business Overview
11.13.3 Cytiva Cellular and Gene Therapy CDMO Introduction
11.13.4 Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.13.5 Cytiva Recent Developments
11.14 Helixmith
11.14.1 Helixmith Company Details
11.14.2 Helixmith Business Overview
11.14.3 Helixmith Cellular and Gene Therapy CDMO Introduction
11.14.4 Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.14.5 Helixmith Recent Developments
11.15 ThermoGenesis
11.15.1 ThermoGenesis Company Details
11.15.2 ThermoGenesis Business Overview
11.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Introduction
11.15.4 ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.15.5 ThermoGenesis Recent Developments
11.16 Anemocyte
11.16.1 Anemocyte Company Details
11.16.2 Anemocyte Business Overview
11.16.3 Anemocyte Cellular and Gene Therapy CDMO Introduction
11.16.4 Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.16.5 Anemocyte Recent Developments
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Introduction
11.17.4 Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.17.5 Thermo Fisher Scientific Recent Developments
11.18 CBM
11.18.1 CBM Company Details
11.18.2 CBM Business Overview
11.18.3 CBM Cellular and Gene Therapy CDMO Introduction
11.18.4 CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.18.5 CBM Recent Developments
11.19 Bio Elpida
11.19.1 Bio Elpida Company Details
11.19.2 Bio Elpida Business Overview
11.19.3 Bio Elpida Cellular and Gene Therapy CDMO Introduction
11.19.4 Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.19.5 Bio Elpida Recent Developments
11.20 Genezen
11.20.1 Genezen Company Details
11.20.2 Genezen Business Overview
11.20.3 Genezen Cellular and Gene Therapy CDMO Introduction
11.20.4 Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.20.5 Genezen Recent Developments
11.21 CCRM
11.21.1 CCRM Company Details
11.21.2 CCRM Business Overview
11.21.3 CCRM Cellular and Gene Therapy CDMO Introduction
11.21.4 CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.21.5 CCRM Recent Developments
11.22 RoslinCT
11.22.1 RoslinCT Company Details
11.22.2 RoslinCT Business Overview
11.22.3 RoslinCT Cellular and Gene Therapy CDMO Introduction
11.22.4 RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.22.5 RoslinCT Recent Developments
11.23 GenScript ProBio
11.23.1 GenScript ProBio Company Details
11.23.2 GenScript ProBio Business Overview
11.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Introduction
11.23.4 GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.23.5 GenScript ProBio Recent Developments
11.24 Oxford BioMedica
11.24.1 Oxford BioMedica Company Details
11.24.2 Oxford BioMedica Business Overview
11.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Introduction
11.24.4 Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.24.5 Oxford BioMedica Recent Developments
11.25 Porton Pharma Solutions
11.25.1 Porton Pharma Solutions Company Details
11.25.2 Porton Pharma Solutions Business Overview
11.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Introduction
11.25.4 Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.25.5 Porton Pharma Solutions Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Viral Vectors
Table 4. Key Players of Plasmid
Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Cellular and Gene Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2018-2023)
Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2024-2033)
Table 11. Cellular and Gene Therapy CDMO Market Trends
Table 12. Cellular and Gene Therapy CDMO Market Drivers
Table 13. Cellular and Gene Therapy CDMO Market Challenges
Table 14. Cellular and Gene Therapy CDMO Market Restraints
Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cellular and Gene Therapy CDMO Revenue Share by Players (2018-2023)
Table 17. Global Top Cellular and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 18. Global Cellular and Gene Therapy CDMO Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Cellular and Gene Therapy CDMO, Headquarters and Area Served
Table 21. Global Key Players of Cellular and Gene Therapy CDMO, Product and Application
Table 22. Global Key Players of Cellular and Gene Therapy CDMO, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2024-2033)
Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cellular and Gene Therapy CDMO Revenue Share by Application (2018-2023)
Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cellular and Gene Therapy CDMO Revenue Share by Application (2024-2033)
Table 32. North America Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Cellular and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Cellular and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Cellular and Gene Therapy CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Cellular and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Cellular and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Cellular and Gene Therapy CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Cellular and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Cellular and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Cellular and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Cellular and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Cellular and Gene Therapy CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Cellular and Gene Therapy CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 64. Catalent Company Details
Table 65. Catalent Business Overview
Table 66. Catalent Cellular and Gene Therapy CDMO Product
Table 67. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 68. Catalent Recent Developments
Table 69. Lonza Company Details
Table 70. Lonza Business Overview
Table 71. Lonza Cellular and Gene Therapy CDMO Product
Table 72. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 73. Lonza Recent Developments
Table 74. Charles River Company Details
Table 75. Charles River Business Overview
Table 76. Charles River Cellular and Gene Therapy CDMO Product
Table 77. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 78. Charles River Recent Developments
Table 79. The Discovery Labs Company Details
Table 80. The Discovery Labs Business Overview
Table 81. The Discovery Labs Cellular and Gene Therapy CDMO Product
Table 82. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 83. The Discovery Labs Recent Developments
Table 84. BIOCENTRIQ Company Details
Table 85. BIOCENTRIQ Business Overview
Table 86. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
Table 87. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 88. BIOCENTRIQ Recent Developments
Table 89. FUJIFILM Diosynth Biotechnologies Company Details
Table 90. FUJIFILM Diosynth Biotechnologies Business Overview
Table 91. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
Table 92. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 93. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 94. Exothera Company Details
Table 95. Exothera Business Overview
Table 96. Exothera Cellular and Gene Therapy CDMO Product
Table 97. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 98. Exothera Recent Developments
Table 99. WuXi AppTec Company Details
Table 100. WuXi AppTec Business Overview
Table 101. WuXi AppTec Cellular and Gene Therapy CDMO Product
Table 102. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 103. WuXi AppTec Recent Developments
Table 104. Pharmaron Company Details
Table 105. Pharmaron Business Overview
Table 106. Pharmaron Cellular and Gene Therapy CDMO Product
Table 107. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 108. Pharmaron Recent Developments
Table 109. OBiO Company Details
Table 110. OBiO Business Overview
Table 111. OBiO Cellular and Gene Therapy CDMO Product
Table 112. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 113. OBiO Recent Developments
Table 114. Cell Therapies Company Details
Table 115. Cell Therapies Business Overview
Table 116. Cell Therapies Cellular and Gene Therapy CDMO Product
Table 117. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 118. Cell Therapies Recent Developments
Table 119. AGC Biologics Company Details
Table 120. AGC Biologics Business Overview
Table 121. AGC Biologics Cellular and Gene Therapy CDMO Product
Table 122. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 123. AGC Biologics Recent Developments
Table 124. Cytiva Company Details
Table 125. Cytiva Business Overview
Table 126. Cytiva Cellular and Gene Therapy CDMO Product
Table 127. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 128. Cytiva Recent Developments
Table 129. Helixmith Company Details
Table 130. Helixmith Business Overview
Table 131. Helixmith Cellular and Gene Therapy CDMO Product
Table 132. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 133. Helixmith Recent Developments
Table 134. ThermoGenesis Company Details
Table 135. ThermoGenesis Business Overview
Table 136. ThermoGenesis Cellular and Gene Therapy CDMO Product
Table 137. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 138. ThermoGenesis Recent Developments
Table 139. Anemocyte Company Details
Table 140. Anemocyte Business Overview
Table 141. Anemocyte Cellular and Gene Therapy CDMO Product
Table 142. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 143. Anemocyte Recent Developments
Table 144. Thermo Fisher Scientific Company Details
Table 145. Thermo Fisher Scientific Business Overview
Table 146. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product
Table 147. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 148. Thermo Fisher Scientific Recent Developments
Table 149. CBM Company Details
Table 150. CBM Business Overview
Table 151. CBM Cellular and Gene Therapy CDMO Product
Table 152. CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 153. CBM Recent Developments
Table 154. Bio Elpida Company Details
Table 155. Bio Elpida Business Overview
Table 156. Bio Elpida Cellular and Gene Therapy CDMO Product
Table 157. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 158. Bio Elpida Recent Developments
Table 159. Genezen Company Details
Table 160. Genezen Business Overview
Table 161. Genezen Cellular and Gene Therapy CDMO Product
Table 162. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 163. Genezen Recent Developments
Table 164. CCRM Company Details
Table 165. CCRM Business Overview
Table 166. CCRM Cellular and Gene Therapy CDMO Product
Table 167. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 168. CCRM Recent Developments
Table 169. RoslinCT Company Details
Table 170. RoslinCT Business Overview
Table 171. RoslinCT Cellular and Gene Therapy CDMO Product
Table 172. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 173. RoslinCT Recent Developments
Table 174. GenScript ProBio Company Details
Table 175. GenScript ProBio Business Overview
Table 176. GenScript ProBio Cellular and Gene Therapy CDMO Product
Table 177. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 178. GenScript ProBio Recent Developments
Table 179. Oxford BioMedica Company Details
Table 180. Oxford BioMedica Business Overview
Table 181. Oxford BioMedica Cellular and Gene Therapy CDMO Product
Table 182. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 183. Oxford BioMedica Recent Developments
Table 184. Porton Pharma Solutions Company Details
Table 185. Porton Pharma Solutions Business Overview
Table 186. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product
Table 187. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 188. Porton Pharma Solutions Recent Developments
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cellular and Gene Therapy CDMO Market Share by Type: 2022 VS 2033
Figure 3. Cell Therapy Features
Figure 4. Viral Vectors Features
Figure 5. Plasmid Features
Figure 6. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Cellular and Gene Therapy CDMO Market Share by Application: 2022 VS 2033
Figure 8. Commercial Case Studies
Figure 9. Academic Research Case Studies
Figure 10. Others Case Studies
Figure 11. Cellular and Gene Therapy CDMO Report Years Considered
Figure 12. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cellular and Gene Therapy CDMO Market Share by Region: 2022 VS 2033
Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Players in 2022
Figure 16. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 18. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 20. North America Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 21. North America Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 22. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cellular and Gene Therapy CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 26. Europe Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 27. Europe Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 28. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Cellular and Gene Therapy CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 36. China Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 37. Asia Cellular and Gene Therapy CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 39. Asia Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 40. Asia Cellular and Gene Therapy CDMO Market Share by Region (2018-2033)
Figure 41. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 51. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 58. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 59. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 60. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 61. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 63. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 64. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 65. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 66. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 67. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 68. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 69. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 70. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 71. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 72. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 74. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 75. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 76. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 77. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 78. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 79. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 80. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 81. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed